Filamentous Hemagglutinin Protein (FHA)

Produktnummer ABIN934427

Dieses Native Filamentous Hemagglutinin-Protein wird in Bordetella pertussis produziert.

Kurzübersicht für Filamentous Hemagglutinin Protein (FHA) (ABIN934427)

Target: Filamentous Hemagglutinin (FHA)

Protein-Typ: Native

Spezies: Human

Quelle: Bordetella pertussis

Applikation: ELISA

Reinheit: > 95 % pure

Produktdetails

Produktmerkmale: Filamentous Hemagglutinin purified from Bordetella Pertussis
Protein Source: Bordetella Pertussis

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Kommentare:

Custom sizes are available on request to antibodies@fitzgerald-fii.com

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.87 mg/mL

Buffer: Frozen liquid.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: -80 °C

Informationen zur Lagerung: Store at -70 °C.

Antigendetails

Target: Filamentous Hemagglutinin (FHA)

Andere Bezeichnung: Filamentous Hemagglutinin

Substanzklasse: Bacteria Protein

Hintergrund: Filamentous haemagglutinin adhesin (FHA) is an important virulence factor from Bordetella pertussis related to the adhesion and spread of the bacteria through the respiratory tract. Filamentous hemagglutinin is a 220 kDa protein associated with the bacterial surface, but also secreted in substantial amounts. Studies using FHA-deficient B. pertussis strains implicate this protein in tracheal colonization, cell adherence, and invasion of macrophages and epithelial cells by B. pertussis. FHA is a useful tool in immunoassays and whooping cough vaccination studies.
Description: Bordetella Pertussis.
Alternative Names: FHA, Bordetella Pertussis, Purified FHA

Molekulargewicht: 220 kDa